Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Lysogene collaborates with Weizmann Institute of Science on gene therapy for Gaucher and Parkinson's

July 1, 2020

Topline data from pivotal CONNECT-FX study of Zygel in fragile X syndrome

July 1, 2020

A Tau-sand forms of tau?

July 1, 2020

Ongentys tablets approved in Japan for patients with PD with motor fluctuations

June 30, 2020

Boehringer Ingelheim and Hydra Biosciences present new TrpC5 antagonists

June 30, 2020

Xeomin botulinum toxin type A receives marketing approval in Japan

June 30, 2020

Autobahn Therapeutics presents new thyroid hormone receptor beta agonists

June 30, 2020

In-brain direct reprogramming creates neurons, alleviates Parkinson's

June 29, 2020

New Nav1.7 channel blockers identified at Merck & Co.

June 29, 2020

New muscarinic M1 and/or M4 receptor agonists presented by Heptares Therapeutics

June 29, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...